Cardiac magnetic resonance outperforms echocardiography to predict subsequent implantable cardioverter defibrillator therapies in ST-segment elevation myocardial infarction patients.
Marcos-Garcés V, Perez N, Gavara J, Lopez-Lereu MP, Monmeneu JV, Rios-Navarro C, de Dios E, Merenciano-González H, Gabaldon-Pérez A, Ferrero-De-Loma-Osorio Á, Martínez-Brotons Á, Bondanza L, Sánchez-Gómez JM, Albiach C, Nunez J, Bayés-Genís A, Chorro FJ, Ruiz-Granell R, Bodi V.
Marcos-Garcés V, et al. Among authors: ruiz granell r.
Front Cardiovasc Med. 2023 Feb 3;10:991307. doi: 10.3389/fcvm.2023.991307. eCollection 2023.
Front Cardiovasc Med. 2023.
PMID: 36818338
Free PMC article.